Kejing Lao

Xi'an, 710021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Design, synthesis and biological evaluation of quinazoline-carbazole derivatives as dual TXNIP/DYRK1A inhibitors for the treatment of type 2 diabetes mellitus.

Design, synthesis and biological evaluation of quinazoline-carbazole derivatives as dual TXNIP/DYRK1A inhibitors for the treatment of type 2 diabetes mellitus.

Journal: Molecular diversity

Published: June 24, 2026

Discovery of ferulic acid carbamate derivatives as dual-targeting agents of BuChE and Nrf2 for Alzheimer's disease.

Discovery of ferulic acid carbamate derivatives as dual-targeting agents of BuChE and Nrf2 for Alzheimer's disease.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: March 24, 2026

From predictive biomarker to therapeutic target: the dual role of SLFN11 in chemotherapy sensitivity.

From predictive biomarker to therapeutic target: the dual role of SLFN11 in chemotherapy sensitivity.

Journal: Cancer chemotherapy and pharmacology

Published: March 03, 2025

Lab on a single microbead: An enzyme-free strategy for the sensitive detection of microRNA via efficient localized catalytic hairpin assembly.

Lab on a single microbead: An enzyme-free strategy for the sensitive detection of microRNA via efficient localized catalytic hairpin assembly.

Journal: Analytica chimica acta

Published: December 03, 2024

Amyloid-beta Targeted Therapeutic Approaches for Alzheimer's Disease: Long Road Ahead.

Amyloid-beta Targeted Therapeutic Approaches for Alzheimer's Disease: Long Road Ahead.

Journal: Current drug targets

Published: January 05, 2022

Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease.

Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease.

Journal: Molecular and cellular neurosciences

Published: March 15, 2021

Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer's Disease.

Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: January 18, 2021

(m)RVD-hemopressin (α) and (m)VD-hemopressin (α) improve the memory-impairing effect of scopolamine in novel object and object location recognition tasks in mice.

(m)RVD-hemopressin (α) and (m)VD-hemopressin (α) improve the memory-impairing effect of scopolamine in novel object and object location recognition tasks in mice.

Journal: Peptides

Published: September 08, 2020

AMPK alleviates oxidative stress‑induced premature senescence via inhibition of NF-κB/STAT3 axis-mediated positive feedback loop.

AMPK alleviates oxidative stress‑induced premature senescence via inhibition of NF-κB/STAT3 axis-mediated positive feedback loop.

Journal: Mechanisms of ageing and development

Published: March 03, 2020

Effect of (m)VD-hemopressin against Aβ1-42-induced oxidative stress and apoptosis in mouse hippocampal neurons.

Effect of (m)VD-hemopressin against Aβ1-42-induced oxidative stress and apoptosis in mouse hippocampal neurons.

Journal: Peptides

Published: September 21, 2019

Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists.

Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: August 31, 2019

Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease.

Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: February 12, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026